The tale of 2 trials: Disentangling contradictory evidence on hypertonic saline for acute bronchiolitis

JAMA Pediatrics

Volumn 168, Issue 7, 2014, Pages 607-609

  Grewal, Sim ^a   Klassen, Terry P ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL; SODIUM CHLORIDE;

ACUTE BRONCHIOLITIS; BRONCHIOLITIS; CHILD HOSPITALIZATION; CLINICAL DECISION MAKING; DRUG EFFICACY; EDITORIAL; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; META ANALYSIS (TOPIC); NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS; SAMPLE SIZE; SYSTEMATIC REVIEW (TOPIC);

ALBUTEROL; BRONCHIOLITIS; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; FEMALE; HUMANS; LENGTH OF STAY; MALE; SALINE SOLUTION, HYPERTONIC;

EID: 84904150815     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2014.423     Document Type: Editorial

References (10)

1. Wu S, Baker C, Lang ME, et al. Nebulized hypertonic saline for bronchiolitis: a randomized clinical trial [published online May 26, 2014]. JAMA Pediatr. doi:10.1001/jamapediatrics.2014.301.
2. Florin TA, Shaw KN, Kittick M, Yackscoe S, Zorc JJ. Nebulized hypertonic saline for bronchiolitis in the emergency department: a randomized clinical trial [published online May 26, 2014]. JAMA Pediatr. doi:10.1001/jamapediatrics. 2013.5306.
3. Thomson D, Hartling L, Cohen E, Vandermeer B, Tjosvold L, Klassen TP. Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006. PLoS One. 2010;5(9):e13106. doi:10.1371/journal.pone.0013106.
4. Rennie D, Chalmers I. Exposing the dangers to patients of medical reviews and textbooks that ignore scientific principles. JLL Bulletin: Commentaries on the History of Treatment Evaluation; 2009. http://www.jameslindlibrary.org /illustrating/articles/exposing-the-dangers-to -patients-of-medical-reviews-and- textbook.pdf. Accessed April 9, 2014.
5. Hartling L, Fernandes RM, Bialy L, et al. Steroids and bronchodilators for bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ. 2011;342:d1714. doi:10.1136/bmj.d1714.
6. Ioannidis J, Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulativemetaanalyses. Proc Natl Acad Sci U S A. 2001;98(3):831-836. (Pubitemid 32121147)
7. Hartling L, Ospina M, Liang Y, et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ. 2009;339:b4012. doi:10.1136/bmj.b4012.
8. Klassen TP. Determining the benefit of bronchodilators in bronchiolitis: when is there enough benefit to warrant adoption into clinical practice? Arch Pediatr Adolesc Med. 1996;150(11): 1120-1121.
9. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev. 2013;7(4):CD006458. doi:10.1002/14651858.CD006458.pub3.
10. Elliott JH, Turner T, Clavisi O, et al. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med. 2014; 11(2):e1001603. doi:10.1371/journal.pmed.1001603.